GnRH antagonist administration for patients at high risk of severe ovarian hyperstimulation syndrome (OHSS) down regulated GnRH agonist

Trial Profile

GnRH antagonist administration for patients at high risk of severe ovarian hyperstimulation syndrome (OHSS) down regulated GnRH agonist

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Aug 2009

At a glance

  • Drugs Ganirelix (Primary) ; Gonadotropin releasing hormone stimulants; Menotropin
  • Indications Infertility; Ovarian hyperstimulation syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 09 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top